Voyager Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VYGR for the last quarter is 90.06 M USD, and it's 1851.91% higher compared to the previous quarter. The net income of Q4 23 is 56.40 M USD.